From our Bureau of Socialist Priorities with some assistance from our Bureau of Latrine American Socialist Healthcare
Esto le pone la tapa al pomo, as Cubans would say, equivalent to the English expression “this takes the cake.”
While Cubans suffer from a drug shortage –often depending on their relatives in the diaspora to keep them supplied with their medications — Castro, Inc. manufactures and sells those scarce drugs to its new best friend, Mexico.
Aaaah, those lovely socialist values. Keeping the oligarchs in power is always the top priority. To hell with the people.
Loosely translated from Diario de Cuba
Despite the shortage of drugs in Cuba, the regime sells medicines to Mexico for a value of 84 million dollars, according to the Government of Andrés Manuel López Obrador, regarding the visit of Miguel Díaz-Canel to that country last Saturday.
“Derived from the consolidated purchase of medicines made by Mexico for 2023-2024, 19 keys were awarded to Cuba in the areas of anesthesiology, pulmonology, ophthalmology and for cancer treatment,” said the Secretary of Health, Jorge Alcocer Varela.
According to Alcocer Varela, the amount destined for the purchase of these Cuban pharmaceutical products reaches a maximum amount of 1,576 million 113,359 Mexican pesos (about 84 million dollars).
Cancer is one of the three leading causes of death in Cuba, and since the year 2000 it is the main reason for a lower life expectancy. In the midst of this panorama, and due to the shortage, many Cubans are forced to go to social networks, a relative abroad or the black market to get all kinds of medicines, including those against cancer.
In August of last year, the general director of the AICA Laboratories company, Emilio Vallín García, acknowledged to the Granma newspaper that the production of cytostatics to treat different types of cancer was unstable. He was only guaranteed the production of some, for a period of three months.
Of 15 cytostatics that this company manufactures, four were missing on that date due to “problems in financing and the arrival of raw materials and other inputs.”
Continue reading HERE in Spanish